Intuitive Surgical (NASDAQ:ISRG) Price Target Lowered to $305.00 at Citigroup

Intuitive Surgical (NASDAQ:ISRGGet Rating) had its target price decreased by investment analysts at Citigroup from $360.00 to $305.00 in a research note issued to investors on Tuesday, The Fly reports. Citigroup’s price target would indicate a potential upside of 38.93% from the company’s previous close.

ISRG has been the topic of a number of other research reports. Evercore ISI decreased their price target on shares of Intuitive Surgical from $294.00 to $280.00 in a research note on Friday, April 22nd. Deutsche Bank Aktiengesellschaft decreased their price target on shares of Intuitive Surgical from $323.00 to $300.00 and set a “hold” rating on the stock in a research note on Friday, January 21st. Morgan Stanley decreased their price target on shares of Intuitive Surgical from $325.00 to $300.00 and set an “equal weight” rating on the stock in a research note on Monday, April 25th. Stifel Nicolaus reduced their target price on shares of Intuitive Surgical from $370.00 to $325.00 and set a “buy” rating on the stock in a research note on Friday, January 21st. Finally, Wells Fargo & Company reduced their target price on shares of Intuitive Surgical from $350.00 to $339.00 and set an “overweight” rating on the stock in a research note on Friday, April 22nd. Eight investment analysts have rated the stock with a hold rating, twelve have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus target price of $323.70.

Shares of ISRG stock opened at $219.53 on Tuesday. Intuitive Surgical has a 1 year low of $206.60 and a 1 year high of $369.69. The firm’s fifty day simple moving average is $268.06 and its 200 day simple moving average is $302.27. The firm has a market capitalization of $78.80 billion, a P/E ratio of 48.82, a price-to-earnings-growth ratio of 5.10 and a beta of 1.26.

Intuitive Surgical (NASDAQ:ISRGGet Rating) last announced its earnings results on Thursday, April 21st. The medical equipment provider reported $1.00 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.93 by $0.07. Intuitive Surgical had a net margin of 27.84% and a return on equity of 14.16%. The business had revenue of $1.49 billion for the quarter, compared to analyst estimates of $1.43 billion. During the same quarter in the previous year, the firm posted $1.17 earnings per share. Intuitive Surgical’s revenue was up 15.1% compared to the same quarter last year. As a group, equities analysts anticipate that Intuitive Surgical will post 4.14 EPS for the current fiscal year.

In other Intuitive Surgical news, EVP Myriam Curet sold 2,478 shares of the business’s stock in a transaction dated Wednesday, February 16th. The stock was sold at an average price of $289.00, for a total transaction of $716,142.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Insiders own 0.90% of the company’s stock.

A number of large investors have recently made changes to their positions in ISRG. Hexagon Capital Partners LLC increased its stake in shares of Intuitive Surgical by 200.0% in the 4th quarter. Hexagon Capital Partners LLC now owns 69 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 46 shares during the last quarter. Paragon Capital Management Ltd bought a new stake in shares of Intuitive Surgical in the 4th quarter valued at about $26,000. Hanseatic Management Services Inc. increased its stake in shares of Intuitive Surgical by 200.0% in the 4th quarter. Hanseatic Management Services Inc. now owns 72 shares of the medical equipment provider’s stock valued at $26,000 after acquiring an additional 48 shares during the last quarter. Standard Family Office LLC bought a new stake in shares of Intuitive Surgical in the 4th quarter valued at about $27,000. Finally, Wolff Wiese Magana LLC increased its stake in shares of Intuitive Surgical by 1,000.0% in the 4th quarter. Wolff Wiese Magana LLC now owns 77 shares of the medical equipment provider’s stock valued at $28,000 after acquiring an additional 70 shares during the last quarter. 83.69% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Company Profile (Get Rating)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Recommended Stories

The Fly logo

Analyst Recommendations for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.